Clinical Trial Update: A Multicenter, Randomized, Double-blind, Parallel Group Study to Determine the Optimal Dose of HL301 After 7 Days Oral Administration in Acute Bronchitis or Acute Exacerbations of Chronic Bronchitis Patients (HL301: Mixed Extract of Rehmannia Glutinosa, Schisandra and so on) [Phase 2]

View source ↗

Summary

A Phase 2 multicenter, randomized, double-blind trial evaluated the dose optimization of HL301 (mixed extract of Rehmannia glutinosa, Schisandra, and others) af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Exacerbations of Chronic Bronchitis

Drugs mentioned

• HL301

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Acute Bronchitis, Acute Exacerbations of Chronic Bronchitis | Phase 2 | Status: COMPLETED